Ogre

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease2 trials
• Familial hypercholesterolaemia2 trials
• Peripheral artery disease1 trial
• Stroke1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials

Running trials

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

  NCT05192941· Phase 4· Novartis Pharmaceuticals· Source